Search for other papers by Deborah Cosentini in
Google Scholar
PubMed
Search for other papers by Salvatore Grisanti in
Google Scholar
PubMed
Search for other papers by Alberto Dalla Volta in
Google Scholar
PubMed
Search for other papers by Marta Laganà in
Google Scholar
PubMed
Search for other papers by Chiara Fiorentini in
Google Scholar
PubMed
Search for other papers by Paola Perotti in
Google Scholar
PubMed
Search for other papers by Sandra Sigala in
Google Scholar
PubMed
Search for other papers by Alfredo Berruti in
Google Scholar
PubMed
Editorial Adrenocortical carcinoma (ACC) is a rare endocrine neoplasia characterized by an overall dismal prognosis and its clinical manifestations are the consequence of either steroid excess or tumor mass progression ( 1 ). Surgery is the
Berlin Institute of Health (BIH), Berlin, Germany
Department of Nephrology, School of Medicine, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany
Search for other papers by Eric Seidel in
Google Scholar
PubMed
Search for other papers by Gudrun Walenda in
Google Scholar
PubMed
Core Unit Bioinformatics, Berlin Institute of Health, Berlin, Germany
Search for other papers by Clemens Messerschmidt in
Google Scholar
PubMed
Core Unit Bioinformatics, Berlin Institute of Health, Berlin, Germany
Search for other papers by Benedikt Obermayer in
Google Scholar
PubMed
Search for other papers by Mirko Peitzsch in
Google Scholar
PubMed
Search for other papers by Paal Wallace in
Google Scholar
PubMed
Search for other papers by Rohini Bahethi in
Google Scholar
PubMed
Search for other papers by Taekyeong Yoo in
Google Scholar
PubMed
Search for other papers by Murim Choi in
Google Scholar
PubMed
Search for other papers by Petra Schrade in
Google Scholar
PubMed
Search for other papers by Sebastian Bachmann in
Google Scholar
PubMed
Search for other papers by Gerhard Liebisch in
Google Scholar
PubMed
Search for other papers by Graeme Eisenhofer in
Google Scholar
PubMed
Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
Search for other papers by Dieter Beule in
Google Scholar
PubMed
Berlin Institute of Health (BIH), Berlin, Germany
Department of Nephrology, School of Medicine, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany
Search for other papers by Ute I Scholl in
Google Scholar
PubMed
, Berlin) for bioinformatics support. References 1 Fassnacht M Kroiss M Allolio B . Update in adrenocortical carcinoma . Journal of Clinical Endocrinology and Metabolism 2013 4551 – 4564 . ( https://doi.org/10.1210/jc.2013-3020 ) 2
Dipartimento di Medicina Clinica e Chirurgia, Università Federico II, Naples, Italy
Search for other papers by Maria Cristina De Martino in
Google Scholar
PubMed
Search for other papers by Richard A Feelders in
Google Scholar
PubMed
Search for other papers by Claudia Pivonello in
Google Scholar
PubMed
Search for other papers by Chiara Simeoli in
Google Scholar
PubMed
Search for other papers by Fortuna Papa in
Google Scholar
PubMed
Search for other papers by Annamaria Colao in
Google Scholar
PubMed
Search for other papers by Rosario Pivonello in
Google Scholar
PubMed
Search for other papers by Leo J Hofland in
Google Scholar
PubMed
Introduction Adrenocortical carcinomas (ACCs) are rare tumors with scant treatment options for which new treatments are required ( 1 , 2 , 3 ). The limited efficacy of conventional antineoplastic treatment in ACCs increases the need for
Jawaharlal Nehru Medical College, Belagavi, India
Search for other papers by Manjunath Goroshi in
Google Scholar
PubMed
Search for other papers by Swati S Jadhav in
Google Scholar
PubMed
Search for other papers by Vijaya Sarathi in
Google Scholar
PubMed
Search for other papers by Anurag R Lila in
Google Scholar
PubMed
Search for other papers by Virendra A Patil in
Google Scholar
PubMed
Search for other papers by Ravikumar Shah in
Google Scholar
PubMed
Search for other papers by Priya Hira in
Google Scholar
PubMed
Search for other papers by Rajaram Sharma in
Google Scholar
PubMed
Search for other papers by Shettepppa Goroshi in
Google Scholar
PubMed
Search for other papers by Gwendolyn Fernandes in
Google Scholar
PubMed
Search for other papers by Amey Rojekar in
Google Scholar
PubMed
Search for other papers by Abhay Dalvi in
Google Scholar
PubMed
Search for other papers by Ganesh Bakshi in
Google Scholar
PubMed
Search for other papers by Gagan Prakash in
Google Scholar
PubMed
Search for other papers by Nalini S Shah in
Google Scholar
PubMed
Search for other papers by Tushar R Bandgar in
Google Scholar
PubMed
adrenocortical carcinoma (ACC, 8%), phaeochromocytoma (PCC, 7%) and adrenal metastasis (AM, 5%) are other less common masses ( 1 ). Most crucial step in management of an adrenal incidentaloma is to differentiate a benign ‘leave-alone’ lesion, from the one that
Search for other papers by L Ghataore in
Google Scholar
PubMed
Search for other papers by I Chakraborti in
Google Scholar
PubMed
Search for other papers by S J Aylwin in
Google Scholar
PubMed
Search for other papers by K-M Schulte in
Google Scholar
PubMed
Departments of, Clinical Biochemistry, Medicine, Department of Endocrinology and Internal Medicine, King's College Hospital, London SE5 9RS, UK
Search for other papers by D Dworakowska in
Google Scholar
PubMed
Search for other papers by P Coskeran in
Google Scholar
PubMed
Search for other papers by N F Taylor in
Google Scholar
PubMed
Introduction Mitotane (o,p'-DDD) plays an important role in adjuvant therapy of adrenocortical carcinoma (ACC) and in advanced stage disease (1) . This application was first reported in 1959 by Bergenstal et al . (2) , but mitotane has only been
INSERM, University of Rouen, Department of Endocrinology, Departments of Endocrinology, Pathology, Department of Pathology, Department of Endocrinology, INSERM, U982, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Institute for Research and Innovation in Biomedicine, Mont‐Saint‐Aignan, France
Search for other papers by Milène Tetsi Nomigni in
Google Scholar
PubMed
Search for other papers by Sophie Ouzounian in
Google Scholar
PubMed
Search for other papers by Alice Benoit in
Google Scholar
PubMed
Search for other papers by Jacqueline Vadrot in
Google Scholar
PubMed
Search for other papers by Frédérique Tissier in
Google Scholar
PubMed
INSERM, University of Rouen, Department of Endocrinology, Departments of Endocrinology, Pathology, Department of Pathology, Department of Endocrinology, INSERM, U982, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Institute for Research and Innovation in Biomedicine, Mont‐Saint‐Aignan, France
Search for other papers by Sylvie Renouf in
Google Scholar
PubMed
INSERM, University of Rouen, Department of Endocrinology, Departments of Endocrinology, Pathology, Department of Pathology, Department of Endocrinology, INSERM, U982, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Institute for Research and Innovation in Biomedicine, Mont‐Saint‐Aignan, France
INSERM, University of Rouen, Department of Endocrinology, Departments of Endocrinology, Pathology, Department of Pathology, Department of Endocrinology, INSERM, U982, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Institute for Research and Innovation in Biomedicine, Mont‐Saint‐Aignan, France
Search for other papers by Hervé Lefebvre in
Google Scholar
PubMed
INSERM, University of Rouen, Department of Endocrinology, Departments of Endocrinology, Pathology, Department of Pathology, Department of Endocrinology, INSERM, U982, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Institute for Research and Innovation in Biomedicine, Mont‐Saint‐Aignan, France
Search for other papers by Sophie Christin-Maitre in
Google Scholar
PubMed
INSERM, University of Rouen, Department of Endocrinology, Departments of Endocrinology, Pathology, Department of Pathology, Department of Endocrinology, INSERM, U982, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Institute for Research and Innovation in Biomedicine, Mont‐Saint‐Aignan, France
Search for other papers by Estelle Louiset in
Google Scholar
PubMed
androgen and cortisol oversecretion is highly suggestive of adrenocortical carcinoma (12) . In very few cases, androgen-secreting adrenal lesions have been identified as bilateral macronodular hyperplasia (13, 14) , adenoma (15) , primary pigmented
Assistance Publique Hôpitaux de Paris (APHP), Department of Endocrinology and Diabetes for Children, Bicêtre Paris-Sud, Le Kremlin Bicêtre, France
Search for other papers by Emmanuelle Motte in
Google Scholar
PubMed
APHP, Plateforme d’Expertise Maladies Rares Paris Sud, Bicêtre Paris Sud Hospital, Le Kremlin Bicêtre, France
Search for other papers by Anya Rothenbuhler in
Google Scholar
PubMed
Search for other papers by Stephan Gaillard in
Google Scholar
PubMed
Search for other papers by Najiba Lahlou in
Google Scholar
PubMed
APHP, Plateforme d’Expertise Maladies Rares Paris Sud, Bicêtre Paris Sud Hospital, Le Kremlin Bicêtre, France
Search for other papers by Cécile Teinturier in
Google Scholar
PubMed
Search for other papers by Régis Coutant in
Google Scholar
PubMed
APHP, Plateforme d’Expertise Maladies Rares Paris Sud, Bicêtre Paris Sud Hospital, Le Kremlin Bicêtre, France
Search for other papers by Agnès Linglart in
Google Scholar
PubMed
cytotoxic effect on the zona reticularis of adrenal glands ( 17 , 18 , 19 ). Its therapeutic use has been validated in adults with metastatic adrenocortical carcinoma, with a target concentration of 14–20 mg/L. At lower concentrations, mitotane reduces
Search for other papers by Gamze Akkuş in
Google Scholar
PubMed
Search for other papers by Isa Burak Güney in
Google Scholar
PubMed
Search for other papers by Fesih Ok in
Google Scholar
PubMed
Search for other papers by Mehtap Evran in
Google Scholar
PubMed
Search for other papers by Volkan Izol in
Google Scholar
PubMed
Search for other papers by Şeyda Erdoğan in
Google Scholar
PubMed
Search for other papers by Yıldırım Bayazıt in
Google Scholar
PubMed
Search for other papers by Murat Sert in
Google Scholar
PubMed
Search for other papers by Tamer Tetiker in
Google Scholar
PubMed
adrenocortical adenoma (Weiss criteria <4) and two as adrenocortical carcinoma. One of the two patients with adrenocortical carcinoma was diagnosed with pheochromocytoma (Pass criteria >4, SUV max 8.2). The other patient had a non-secretory adrenocortical
Armed Forces College of Medicine, Cairo, Egypt
Search for other papers by Wafaa M Rashed in
Google Scholar
PubMed
Search for other papers by Anas Saad in
Google Scholar
PubMed
Search for other papers by Muneer Al-Husseini in
Google Scholar
PubMed
Search for other papers by Ahmed Mahmoud Galal in
Google Scholar
PubMed
Search for other papers by Assem Mohamed Ismael in
Google Scholar
PubMed
Search for other papers by Ahmed M Al-Tayep in
Google Scholar
PubMed
Search for other papers by Ayman El Shafie in
Google Scholar
PubMed
Search for other papers by Mahmoud Ahmed Ali in
Google Scholar
PubMed
Search for other papers by Ahmad Samir Alfaar in
Google Scholar
PubMed
adrenal gland tumors and BRCA1 or BRCA2 mutations. These genetic associations should be investigated in large longitudinal study of primary breast cancer and adrenal gland tumor as a second malignancy. The incidence of adrenocortical carcinomas (ACCs) as
Search for other papers by Boju Pan in
Google Scholar
PubMed
Search for other papers by Anqi Wang in
Google Scholar
PubMed
Search for other papers by Junyi Pang in
Google Scholar
PubMed
Search for other papers by Yuhan Zhang in
Google Scholar
PubMed
Search for other papers by Ming Cui in
Google Scholar
PubMed
Search for other papers by Jian Sun in
Google Scholar
PubMed
Search for other papers by Zhiyong Liang in
Google Scholar
PubMed
parathyroid adenoma and carcinoma. Numerous studies have revealed PD-L1 expression in endocrine tumors, including pituitary tumors ( 11 ), papillary thyroid carcinomas ( 12 , 13 ), adrenocortical carcinomas ( 14 ), pheochromocytomas ( 15 ) and